scholarly article | Q13442814 |
P2093 | author name string | Jianfei Qi | |
Ladan Fazli | |||
Martin Gleave | |||
Arif Hussain | |||
Xuesen Dong | |||
Lingling Fan | |||
Xiaolu Cui | |||
Fengbo Zhang | |||
Songhui Xu | |||
P2860 | cites work | Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival | Q21091046 |
NF-κB2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer | Q38865962 | ||
Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas | Q38967517 | ||
Activation of alpha-tropomyosin exon 2 is regulated by the SR protein 9G8 and heterogeneous nuclear ribonucleoproteins H and F. | Q39127727 | ||
Androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines | Q39250655 | ||
Intronic splicing enhancers, cognate splicing factors and context-dependent regulation rules | Q39277603 | ||
Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer. | Q39329100 | ||
Intragenic rearrangement and altered RNA splicing of the androgen receptor in a cell-based model of prostate cancer progression | Q39605639 | ||
Role of Jhdm2a in regulating metabolic gene expression and obesity resistance | Q41876713 | ||
Heterochromatin protein 1 (HP1a) positively regulates euchromatic gene expression through RNA transcript association and interaction with hnRNPs in Drosophila | Q41951844 | ||
The generally expressed hnRNP F is involved in a neural-specific pre-mRNA splicing event | Q46698520 | ||
Integrative Clinical Genomics of Advanced Prostate Cancer. | Q53788627 | ||
Heterogeneous nuclear ribonucleoprotein F/H proteins modulate the alternative splicing of the apoptotic mediator Bcl-x | Q81662355 | ||
JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor | Q24315882 | ||
A combinatorial code for splicing silencing: UAGG and GGGG motifs | Q24792190 | ||
Intronic binding sites for hnRNP A/B and hnRNP F/H proteins stimulate pre-mRNA splicing | Q25256959 | ||
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer | Q26777310 | ||
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer | Q27853062 | ||
A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth | Q28116222 | ||
The secondary structure of the human immunodeficiency virus type 1 transcript modulates viral splicing and infectivity | Q30440740 | ||
Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer | Q30485336 | ||
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant | Q30495758 | ||
Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta | Q30815190 | ||
JMJD6 and U2AF65 co-regulate alternative splicing in both JMJD6 enzymatic activity dependent and independent manner. | Q33558243 | ||
The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells | Q33728316 | ||
A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H. | Q33954292 | ||
Regulation of alternative splicing by histone modifications | Q34035543 | ||
Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor | Q34165500 | ||
NMR structure of the three quasi RNA recognition motifs (qRRMs) of human hnRNP F and interaction studies with Bcl-x G-tract RNA: a novel mode of RNA recognition | Q34977477 | ||
Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1. | Q35575633 | ||
Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies | Q35842471 | ||
Influence of RNA secondary structure on the pre-mRNA splicing process | Q35968217 | ||
Mechanisms of the androgen receptor splicing in prostate cancer cells | Q36005683 | ||
Androgen Receptor Splice Variants Dimerize to Transactivate Target Genes | Q36021859 | ||
Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival | Q36590632 | ||
Heterogeneous nuclear ribonucleoproteins H and F regulate the proteolipid protein/DM20 ratio by recruiting U1 small nuclear ribonucleoprotein through a complex array of G runs | Q37160862 | ||
Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53. | Q37478627 | ||
High levels of the AR-V7 Splice Variant and Co-Amplification of the Golgi Protein Coding YIPF6 in AR Amplified Prostate Cancer Bone Metastases | Q38718521 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | alternative mRNA splicing, via spliceosome | Q21114084 |
P577 | publication date | 2018-04-30 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Histone demethylase JMJD1A promotes alternative splicing of AR variant 7 (AR-V7) in prostate cancer cells. |
Q92023458 | A positive role of c-Myc in regulating androgen receptor and its splice variants in prostate cancer |
Q91900019 | AKR1C3 Promotes AR-V7 Protein Stabilization and Confers Resistance to AR-Targeted Therapies in Advanced Prostate Cancer |
Q58598144 | Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer |
Q90091985 | Androgen receptor variant-driven prostate cancer II: advances in laboratory investigations |
Q92316366 | Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications |
Q91151375 | Epigenetic regulation of lung cancer cell proliferation and migration by the chromatin remodeling protein BRG1 |
Q57106917 | Genetics and biology of prostate cancer |
Q90835355 | Histone demethylase JMJD1A promotes expression of DNA repair factors and radio-resistance of prostate cancer cells |
Q97681497 | Identification of long non-coding RNAs in advanced prostate cancer associated with androgen receptor splicing factors |
Q97646705 | Role of H3K9 demethylases in DNA double-strand break repair |
Q89919982 | Roles of Splicing Factors in Hormone-Related Cancer Progression |
Q64967604 | Splicing Factors Have an Essential Role in Prostate Cancer Progression and Androgen Receptor Signaling. |
Q90059156 | Targeting USP1-dependent KDM4A protein stability as a potential prostate cancer therapy |
Q99711645 | The Crosstalk Between Epigenetic Mechanisms and Alternative RNA Processing Regulation |
Q91826178 | Understanding aberrant RNA splicing to facilitate cancer diagnosis and therapy |
Search more.